期刊文献+

232株鲍曼不动杆菌临床分布及耐药性分析 被引量:1

Clinical Distribution and Drug Resistance Analysis on 232 Acinetobacter Baumannii
下载PDF
导出
摘要 目的:了解鲍曼不动杆菌临床分布及耐药谱变化趋势,以指导临床合理用药。方法:调查我院住院患者临床送检的痰、尿、血、分泌物等标本,用BD公司Phoenix100自动化细菌鉴定及药敏分析仪对菌落进行鉴定并做药敏试验,对检出的鲍曼不动杆菌药敏结果及科室分布做一分析。结果:检出鲍曼不动杆菌232株,其中主要为痰标本185例,占79.7%。鲍曼不动杆菌对亚胺培南耐药率为20.7%。对其它抗生素耐药率均在50%以上。结论:鲍曼不动杆菌对抗菌药物已产生多重耐药,应当尽早阻止多重耐药菌株的扩散,预防医院感染的发生,以便指导临床合理使用抗生素。 Objective:To understand the clinical distribution of acinetobacter baumannii and change tendency of drug resistant spectrum so as to guide reasonable clinical prescription.Method:Patients' sputum,urine,blood and secretion were tested.Colonies identification and drug sensitivity test were performed by PHOENIX 100 automatic bacteria identification and drug sensitivity analyzer.The results were analyzed.Result:232 acinetobacter baumannii were detected,among them,185 cases(79.7%) were sputum specimens.The resistance rate was 20.7% against imipenem and more than 50% against other antibiotics.Conclusion:Acinetobacter baumannii presented multidrug resistance to antibiotics.We should timely prevent the dissemination of multiple antibiotic resistant strains and avoid the incidence of hospital infection so as to guide reasonable use of antibiotics.
作者 马媛
机构地区 北京航天总医院
出处 《内蒙古中医药》 2009年第9期19-20,共2页 Inner Mongolia Journal of Traditional Chinese Medicine
关键词 鲍曼不动杆菌 临床分布 耐药性 Acinetobacter baumannii Clinical distribution Drug resistance
  • 相关文献

参考文献3

二级参考文献18

  • 1[5]赵虎,周庭银.临床微生物学诊断与图解[M].上海:上海科学技术出版社,2001. 139-156.
  • 2National Committee for Clinical Laboratory Standard, 2002. Performance Standards for Antimicrobial Susceptibility Testing. NCCLS, Wayne, Pa.
  • 3Rhomberg PR, Jones RN , MYSTIC Study Group. Antimicrobial spectrum of activity for meropenem and nine broad spectrum antimicrobials:report from the MYSTIC Program (2002) in North America. Diagn Microbiol Infect Dis, 2003,47:365-372.
  • 4Pfaller MA, Jones RN , MYSTIC Study Group. Antimicrobial susceptibility of inducible Amp C β-lactamase-producing Enterobacteriaceae from the Meropenem Yearly Susceptibility Test Information Collection (MYSTIC) Programme, Europe 1997-2000. Int J Antimicrob Agents, 2002,19:383-388.
  • 5Sader HS, Biedenbach DJ ,Jones RN. Global patterns of susceptibility for 21 commonly utilized antimicrobial agents tested against 48440 Enterobacteriaceae in the SENTRY Antimicrobial Surveillance Program (1997-2000). Diagn Microbiol Infect Dis, 2003,47:361-364.
  • 6Sader HS, Gales AC, Pfaller MA, et al. Pathogen frequency and resistance patterns in Brazilian hospitals:summary of results from three years of the SENTRY Antimicrobial Surveillance Program. Braz J Infect Dis, 2001,5:200-214.
  • 7Forster DH, Daschner FD. Acinetobacter species as nosocomial pathogens[J]. Eur J Clin Microbiol Infect Dis, 1998,17 (2) :73 - 77.
  • 8Mahgoub S, Ahmed J, Gatt AE. Underlying characteristics of patients harboring highly resistant Acinetobacter baumannii [ J ]. Am J Infect Control,2002,30(7 ) :386.
  • 9Jacoby GA, Han P. Detection of extended - spectrum bate - lactamases in clinical isolates of klebsiella pneumoniae and Escherichia coli [ J ]. J Clin Miorbiol, 1996,34 (4) :908 - 911.
  • 10徐玲,罗永艾.鲍曼不动杆菌肺部感染及药物敏感性测定[J].中华医院感染学杂志,2000,10(3):234-235. 被引量:25

共引文献354

同被引文献4

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部